EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 27th, 2024 • Biostem Technologies • Florida
This EXECUTIVE EMPLOYMENT AGREEMENT (this ''Agreement") is made and entered into as of this 8th day of January, 2024 (the "Effective Date"), by and between BioStem Technologies, Inc., a Florida corporation (the "Company"), and Shawn McCarrey ("Executive").
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 27th, 2024 • Biostem Technologies • Florida
This EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into as of this 22nd day of July 2022 (the “Effective Date”), by and between BioStem Technologies, Inc., a Florida corporation (the “Company”), and Andrew Van Vurst (“Executive”). Effective as of the Effective Date, any prior employment agreement between the Company and the Executive is hereby deemed amended and restated in its entirety, without any termination or expiration thereunder, to provide as set forth in this Agreement.
Equity Exchange Agreement By and Among BioStem Technologies, Inc. And Andrew Van VurstEquity Exchange Agreement • September 27th, 2024 • Biostem Technologies • Florida
This Equity Exchange Agreement (this “Agreement”) is entered into as of March 31, 2022 (the “Closing Date”), by and among BioStem Technologies, Inc., a Florida corporation (the “Company”) and Andrew Van Vurst (“Creditor”). The Company and Creditor may be collectively referred to herein as the “Parties” and individually as a “Party.”
Amendment No. 1 to Executive Employment AgreementExecutive Employment Agreement • September 27th, 2024 • Biostem Technologies
This Amendment No. 1 to Executive Employment Agreement (this "Amendment") is made and entered into as of this 24th day of October, 2022 (the "Amendment Date"), by and between BioStem Technologies, Inc., a Florida corporation (the "Company"), and Andrew Van Vurst ("Executive"). The Company and Executive may be referred to herein individually as a "Party" and collectively as the "Parties".
Please be advised that certain identified information has been excluded in this Exhibit because it is the type of information that the registrant treats as private or confidential and is (i) not material and (ii) would be competitively harmful if...Distribution and Services Agreement • September 27th, 2024 • Biostem Technologies • Florida
THIS DISTRIBUTION AND SERVICES AGREEMENT ("Agreement") effective as of September 8, 2023 (the "Effective Date"), by and between Venture Medical, LLC with an address of 211 North Higgins Avenue, Suite 305, Missoula, MT 59802 ("Distributor") and BioStem Technologies, Inc., with its principal place of business located at 2836 Center Port Circle, Pompano Beach, FL 33064 ("Company"). Each of Company and Distributor are referred to individually herein as a "Party" and, collectively, as the "Parties."
Amendment No. 1 to Executive Employment AgreementExecutive Employment Agreement • September 27th, 2024 • Biostem Technologies
This Amendment No. 1 to Executive Employment Agreement (this “Amendment”) is made and entered into as of this 24th day of October, 2022 (the “Amendment Date”), by and between BioStem Technologies, Inc., a Florida corporation (the “Company”), and Jason Matuszewski (“Executive”). The Company and Executive may be referred to herein individually as a “Party” and collectively as the “Parties”.
EXCLUSIVE COMMERCIALIZATION AND IP AGREEMENTExclusive Commercialization and Ip Agreement • September 27th, 2024 • Biostem Technologies • Florida
This EXCLUSIVE COMMERCIALIZATION AND INTELLECTUAL PROPERTY (“IP”) AGREEMENT (together with its Exhibit(s), the “Agreement”) is entered into and made effective as of June 29, 2023 (the “Effective Date”) by and between (i) BioStem Technologies, Inc., a Florida corporation (“BioStem”), and (ii) Hesed Life and Medical, LLC, a California limited liability company (“Hesed Life”).
Form of Restricted Unit Award Agreement BioStem Technologies, Inc. Restricted Unit Award AgreementRestricted Unit Award Agreement • September 27th, 2024 • Biostem Technologies • Florida
BioStem Technologies, Inc., a Florida corporation (the “Company”), hereby grants to [_________] (the “Participant”, also referred to as “you”) the Restricted Stock Units (the “Restricted Stock Units” or “RSUs”), pursuant to the terms of the attached Restricted Unit Award Agreement and the BioStem Technologies, Inc. 2022 Equity Incentive Plan, as may be amended from time to time (the “Plan”).
FIRST AMENDMENT TO DISTRIBUTION AND SERVICES AGREEMENTDistribution and Services Agreement • September 27th, 2024 • Biostem Technologies
This First Amendment to Distribution and Services Agreement (this “Amendment”) is made by and between BioStem Technologies, Inc., a Delaware corporation (“Company”) and Venture Medical, LLC, a Montana limited liability company (“Distributor”), is effective as of March 1, 2024 (the “Amendment Effective Date”).
